Axogen Inc Stock Today
AXGN Stock | USD 7.00 0.03 0.43% |
Performance0 of 100
| Odds Of DistressLess than 36
|
Axogen is selling at 7.00 as of the 17th of April 2024; that is -0.43 percent down since the beginning of the trading day. The stock's open price was 7.03. Axogen has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Axogen Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 18th of March 2024 and ending today, the 17th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 27th of March 1990 | Category Healthcare | Classification Health Care |
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. The company has 43.69 M outstanding shares of which 1.73 M shares are presently shorted by private and institutional investors with about 4.81 trading days to cover. More on Axogen Inc
Moving together with Axogen Stock
0.71 | FIGS | Figs Inc Financial Report 2nd of May 2024 | PairCorr |
Moving against Axogen Stock
0.73 | EHAB | Enhabit Financial Report 14th of May 2024 | PairCorr |
0.65 | GCTK | GlucoTrack | PairCorr |
0.63 | PNTG | Pennant Group Financial Report 2nd of May 2024 | PairCorr |
0.62 | ADUS | Addus HomeCare Financial Report 6th of May 2024 | PairCorr |
0.43 | DVA | DaVita HealthCare Financial Report 13th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
Axogen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Axogen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Axogen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO and President and Director | Karen Zaderej | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Health Care, NASDAQ Composite, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation Analysts covering Axogen report their recommendations after researching Axogen's financial statements, talking to executives and customers, or listening in on Axogen's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Axogen Inc. The Axogen consensus assessment is calculated by taking the average forecast from all of the analysts covering Axogen. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength Based on the analysis of Axogen's profitability, liquidity, and operating efficiency, Axogen Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Axogen Inc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Axogen's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Axogen's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Axogen's financial leverage. It provides some insight into what part of Axogen's total assets is financed by creditors.
|
Axogen Inc (AXGN) is traded on NASDAQ Exchange in USA. It is located in 13631 Progress Boulevard, Alachua, FL, United States, 32615 and employs 426 people. Axogen is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 307.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Axogen's market, we take the total number of its shares issued and multiply it by Axogen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Axogen Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 43.69 M outstanding shares of which 1.73 M shares are presently shorted by private and institutional investors with about 4.81 trading days to cover.
Axogen Inc currently holds about 58.03 M in cash with (5.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37.
Check Axogen Probability Of Bankruptcy
Ownership AllocationAxogen Inc retains a total of 43.69 Million outstanding shares. The majority of Axogen Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Axogen Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Axogen. Please pay attention to any change in the institutional holdings of Axogen Inc as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Axogen Ownership Details
Axogen Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Axogen jumping above the current price in 90 days from now is under 95%. The Axogen Inc probability density function shows the probability of Axogen stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.4067. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Axogen will likely underperform. Additionally, axogen Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Axogen to move above the current price in 90 days from now is under 95 (This Axogen Inc probability density function shows the probability of Axogen Stock to fall within a particular range of prices over 90 days) .
Axogen Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Axogen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Axogen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Axogen's value.Instituion | Recorded On | Shares | |
Tocqueville Asset Management L.p. | 2023-12-31 | 769.9 K | |
Silvercrest Asset Management Group Llc | 2023-12-31 | 756.2 K | |
Dimensional Fund Advisors, Inc. | 2023-12-31 | 579.3 K | |
Deutsche Bank Ag | 2023-12-31 | 578.6 K | |
D. E. Shaw & Co Lp | 2023-09-30 | 575.4 K | |
Bank Of America Corp | 2023-12-31 | 521.7 K | |
Northern Trust Corp | 2023-12-31 | 382.3 K | |
Nuveen Asset Management, Llc | 2023-12-31 | 353.1 K | |
Charles Schwab Investment Management Inc | 2023-12-31 | 331.3 K | |
Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2023-12-31 | 5.2 M | |
Blackrock Inc | 2023-12-31 | 3.3 M |
Axogen Historical Income Statement
Axogen Inc Income Statement is one of the three primary financial statements used for reporting Axogen's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Axogen Inc revenue and expense. Axogen Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Axogen's Total Operating Expenses is very stable compared to the past year. As of the 17th of April 2024, Selling General Administrative is likely to grow to about 36.7 M, though Operating Income is likely to grow to (20.4 M). View More FundamentalsAxogen Stock Against Markets
Picking the right benchmark for Axogen stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Axogen stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Axogen is critical whether you are bullish or bearish towards Axogen Inc at a given time. Please also check how Axogen's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Axogen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
All Next | Launch Module |
Axogen Corporate Directors
Axogen corporate directors refer to members of an Axogen board of directors. The board of directors generally takes responsibility for the Axogen's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Axogen's board members must vote for the resolution. The Axogen board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Joseph Mandato | Independent Director | Profile | |
Mike Donovan | Director of Operations | Profile | |
Alan Levine | Director | Profile | |
Guido Neels | Director | Profile |
How to buy Axogen Stock?
Before investing in Axogen, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Axogen. To buy Axogen stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Axogen. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Axogen stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Axogen Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Axogen Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Axogen Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Axogen Stock please use our How to Invest in Axogen guide.
Already Invested in Axogen Inc?
The danger of trading Axogen Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Axogen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Axogen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Axogen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Axogen Inc information on this page should be used as a complementary analysis to other Axogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Axogen Stock analysis
When running Axogen's price analysis, check to measure Axogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axogen is operating at the current time. Most of Axogen's value examination focuses on studying past and present price action to predict the probability of Axogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axogen's price. Additionally, you may evaluate how the addition of Axogen to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Axogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Revenue Per Share 3.708 | Quarterly Revenue Growth 0.187 | Return On Assets (0.07) | Return On Equity (0.22) |
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.